GSEP
BNGO icon

Golden State Equity Partners’s Bionano Genomics BNGO Stock Holding History

Golden State Equity Partners’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-442
Closed -$7.64K – 432
2024
Q4 		$7.64K Buy
+442
New +$7.55K ﹤0.01% 432
2024
Q3 		– Sell
-442
Closed -$18K – 823
2024
Q2 		$18K Buy
+442
New +$24.3K ﹤0.01% 403
2023
Q4 		– Sell
-167
Closed -$30.3K – 364
2023
Q3 		$30.3K Buy
167
+50
+43% +$13.1K 0.01% 334
2023
Q2 		$42.7K Buy
117
+17
+17% +$7.67K 0.01% 367
2023
Q1 		$66.6K Buy
+100
New +$88.8K 0.04% 212
2022
Q1 		$44K Buy
28
+8
+40% +$10.8K 0.02% 189
2021
Q4 		$36K Buy
+20
New +$53.5K 0.02% 172

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Golden State Equity Partners's BNGO Position: Q1 2025 in Review

Golden State Equity Partners sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 442 shares — an estimated $7.64K sold.

Golden State Equity Partners first reported a position in BNGO in Q4 2021 and held it in 7 quarters. The position peaked at $66.6K in Q1 2023. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Golden State Equity Partners reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Golden State Equity Partners sold 442 Bionano Genomics shares in Q1 2025, an estimated $7.64K.
  • Golden State Equity Partners first reported a position in Bionano Genomics in Q4 2021 and held it in 7 quarters.
  • Golden State Equity Partners's Bionano Genomics position peaked at $66.6K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Golden State Equity Partners's 13F filing for Q1 2025, filed 23 Apr 2025.